Smart Investing Blog2023-08-31T12:12:29+00:00
104, 2024

UPS Wins Over U.S. Postal Service as Air Cargo Provider, Replacing FedEx: Is it Time to Buy UPS?

By |April 1st, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

United Parcel Service, or UPS (UPS), will officially replace FedEx as the United States Postal Service’s primary air cargo provider. This comes after FedEx and USPS failed to agree on new contract terms, which were set to expire later this year on September 29th. FedEx wanted to negotiate a better deal, and ultimately, ended up walking away. The two [...]

104, 2024

Market Recap: Mixed Performance as March Ends on Wall Street

By |April 1st, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News|Tags: , , , , |

Monday: Economic Data Weighs on Market Sentiment The week started with a downturn as investors grappled with upcoming economic data releases. The Dow, S&P500, and Nasdaq all recorded losses, slipping by 0.4%, 0.3%, and 0.3%, respectively. Tuesday: Mixed Data Leads to Afternoon Declines Tuesday saw stocks slipping further as investors reacted to a mixed bag of economic indicators. The [...]

2803, 2024

Walgreens is Still Struggling With Profitability After Q2 Earnings Miss: Should You Sell WBA?

By |March 28th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , |

Shares of Walgreens Boots Alliance (WBA) are relatively flat this morning after the company reported second-quarter earnings that have analysts and investors alike concerned about profits and the long-term viability of the company’s business model. Last quarter, we wrote about Walgreens cutting their quarterly dividend and the fallout that ensued - including removal from the Dow Jones Industrial Average. [...]

2703, 2024

Merck Spikes After FDA Approval, Sends Competitors Reeling

By |March 27th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Merck (MRK) received US FDA approval on Tuesday after the market’s close for Winrevair to treat pulmonary arterial hypertension (PAH), causing the stock to climb 4.6% pre-market. The company’s market cap is around $332.7 billion, indicating any notable movement is a result of a significant event, so the approval demonstrates a pretty big win for the medical giant. Let’s [...]

2703, 2024

GameStop Falls 16% on Earnings Miss, Concern of Long-Term Viability: Should You Sell GME?

By |March 27th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , |

Shares of GameStop Corporation (GME) are down more than 16% Wednesday morning after the company came in well short of expectations in the fourth quarter. The video game retailer reported revenue of $1.79 billion, missing the analyst consensus of $2.05 billion by a wide margin. This was a big step backward year over year, too, from $2.23 billion this [...]

2603, 2024

Krispy Kreme Soars 30% on McDonald’s Distribution Partnership, But Is it Enough to Earn DNUT a Buy?

By |March 26th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , |

Krispy Kreme (DNUT) is up more than 30% in Tuesday trading after the Winston-Salem, NC company announced a strategic partnership with worldwide fast-food chain McDonald’s.  The rollout will begin in the back half of this year, at which point customers will be able to buy Krispy Kreme doughnuts at select McDonald’s. The partnership will be nationwide by 2026. The [...]

Analyze Any Stock Free

30-DAY TRIAL

  • FREE MOBILE APP
  • FREE COACHING
  • FREE QUICK START COURSE
Ready to test-drive VectorVest? Sign up now and
try a simpler approach to picking the right stocks.
Go to Top